Olav Zilian
Analyst-Equity at Banque Pictet & Cie SA
Network origin in Olav Zilian first degree
Entity | Entity type | Industry | |
---|---|---|---|
Banque Pictet & Cie SA
Banque Pictet & Cie SA Investment ManagersFinance Banque Pictet & Cie SA is an independent Swiss private bank which specializes in asset and wealth management. Headquartered in Geneva, the firm was founded in 1805 to manage the wealth of private and institutional investors. They do not engage in investment banking and do not issue commercial, mortgage or unsecured loans.
18
| Private Company | Investment Managers | 18 |
10
| Public Company | Biotechnology | 10 |
Mirabaud Securities Ltd. (Switzerland)
4
| Operating Division | Investment Banks/Brokers | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Olav Zilian via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Pictet Asset Management SA
Pictet Asset Management SA Investment ManagersFinance Pictet Asset Management SA (Pictet AM) is the asset management subsidiary of Pictet Asset Management Holding SA, ultimately held by Banque Pictet & Cie in Switzerland. Established in 1967, the firm is headquartered in Geneva with investment management centers in Zurich, London, Singapore and Tokyo. They also have marketing client service centers in major cities worldwide. Pictet AM manages a range of equity, fixed income, alternative and multi asset products. They provide specialist investment services through segregated accounts and investment funds to some of the world’s largest pension funds, financial institutions, sovereign wealth funds, intermediaries and their clients. Pictet AM is a responsible investor and signatory to the UN Principles for Responsible Investment. | Investment Managers | Analyst-Equity Analyst-Equity Analyst-Equity Head-Equity Investments Analyst-Equity | |
Catherex, Inc.
Catherex, Inc. Miscellaneous Commercial ServicesCommercial Services Catherex, Inc. provides medical research services. The company was founded by Michael A. Christini and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Corporate Officer/Principal | |
Vontobel Asset Management AG
Vontobel Asset Management AG Investment ManagersFinance Vontobel Asset Management AG (Vontobel AM) is the asset management subsidiary of Vontobel Holding AG (SWX: VONN) in Switzerland. Founded in 1988, the firm is headquartered in Zurich and manages assets for institutional clients and the Vontobel Group's pension funds. Vontobel AM is a socially responsible investor and signatory to the UN Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
EPIGENOMICS AG | Medical Specialties | Chief Executive Officer | |
Exane SA (Broker)
Exane SA (Broker) Investment Banks/BrokersFinance Exane SA (Broker) (Exane) is the brokerage division of Exane SA, itself a subsidiary of Verner Investissements SAS in France. Established in 2004 as a joint venture between BNP Paribas and Verner Investissements, the firm is based in Paris and specializes in European equity research and broking activities. Exane has research centers in Paris and London which are supported by a team of economists and strategists. | Investment Banks/Brokers | Market Strategist | |
Scibase AB | Director/Board Member | ||
Memo Therapeutics AG
Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member | |
INFLARX N.V. | Biotechnology | Director of Finance/CFO | |
Bluehaven Therapeutics AG | Chief Executive Officer | ||
ImCyse SA
ImCyse SA BiotechnologyHealth Technology ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium. | Biotechnology | Chairman | |
Technical University of Berlin | College/University | Doctorate Degree | |
Immunic AG
Immunic AG Pharmaceuticals: MajorHealth Technology Immunic AG develops pharmaceuticals in the immunology space. The firm offers immune modulators to block TH17-and TH1-mediated immune and autoimmune responses. The company was founded by Andreas Muhler and Manfred Groppel in April 2016 and is headquartered in Martinsried, Germany. | Pharmaceuticals: Major | Director/Board Member | |
SCIBASE HOLDING AB (PUBL) | Medical Specialties | Director/Board Member | |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal | |
BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Chief Executive Officer | |
Sanofi-Aventis Deutschland GmbH
Sanofi-Aventis Deutschland GmbH Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Deutschland GmbH engages in the development, manufacture, and packaging of medicines, as well as pharmaceutical products. It also focuses on the research into the causes of diseases and the search for its drug treatment. The company was founded in 2004 and is headquartered in Frankfurt, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
elbion NV
elbion NV Pharmaceuticals: MajorHealth Technology Elbion NV discovers and develops therapeutics for neurological diseases and immunological disorders. It focuses on the discovery and development of new drugs for CNS and immunological diseases. The company was founded by Dr. Thomas Kronbach and Dr. Bernd Kastler in 2002 and is headquartered in Leuven, Belgium. | Pharmaceuticals: Major | Director of Finance/CFO | |
Biotechnologie-Industrie-Organisation Austria | Chief Executive Officer | ||
invIOs Holding AG | Chief Executive Officer | ||
APEIRON Biologics AG
APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Biotechnology | Chief Executive Officer | |
2INVEST AG | Financial Conglomerates | Director/Board Member | |
Acceleration Partners LLC
Acceleration Partners LLC Advertising/Marketing ServicesCommercial Services Acceleration Partners LLC provides digital strategy and marketing services. It creates customized customer acquisition programs for individual consumer and e-commerce companies. The firm also specializes in organic search, paid marketing and site structures. The company was founded by Robert S. Glazer in 2007 and is headquartered in Needham, MA. | Advertising/Marketing Services | Founder | |
SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Müller Dairy (UK) Ltd.
Müller Dairy (UK) Ltd. Food: Meat/Fish/DairyConsumer Non-Durables Müller Dairy (UK) Ltd. sells diary products. The company's diary products include, Müllerice, Raspberry and Apple 6 pack, Müllerlight, Blackcurrant, Müllerlight Drink and Müllerlight Three New McVities. Müller Dairy was founded in 1986 and is headquartered in Market Drayton, UK. | Food: Meat/Fish/Dairy | Chief Executive Officer | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member | |
PLUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
HEIDELBERG PHARMA AG | Pharmaceuticals: Major | Director of Finance/CFO | |
BASILEA PHARMACEUTICA AG | Pharmaceuticals: Major | Chief Executive Officer | |
ONE swiss bank SA (Investment Management) | Investment Managers | Head-Equity Investments | |
University of Innsbruck | College/University | Doctorate Degree | |
UBS AG (Investment Management)
UBS AG (Investment Management) Investment ManagersFinance UBS AG (Investment Management) (UBS-IM) is the Swiss investment management division of UBS AG, itself a subsidiary of UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. Formerly known as UBS Global Asset Management Switzerland, the firm was founded in 1998 when Union Bank of Switzerland and Swiss Bank Corporation merged. Headquartered in Zurich and has additional office in Basel, UBS-IM manages a range of investment funds and offers investment management services for institutional, corporate and private clients. | Investment Managers | Analyst-Equity | |
Bank Pictet & Cie (Asia) Ltd.
Bank Pictet & Cie (Asia) Ltd. Regional BanksFinance Bank Pictet & Cie (Asia) Ltd. provides private banking services. It specializes in private and institutional asset management, fund administration and management, global custody and family office services. The company is headquartered in Singapore. | Regional Banks | Corporate Officer/Principal | |
Basilea Pharmaceutical International Ltd. | Chief Executive Officer | ||
Kidpharma AG
Kidpharma AG Pharmaceuticals: MajorHealth Technology Kidpharma AG manufactures pharmaceutical products. The private company is based in Root, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree | |
Utah State University | College/University | Undergraduate Degree | |
Prudential Investment Corp.
Prudential Investment Corp. Investment ManagersFinance Part of Prudential Financial, Inc., Prudential Investment Corp. provides investment advice. The company is based in Grass Lake, MI. | Investment Managers | Director of Finance/CFO | |
USC Marshall School of Business | College/University | Masters Business Admin | |
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd.
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. BiotechnologyHealth Technology MSD Wellcome Trust Hilleman Laboratories Pvt Ltd. develops and researches vaccines. The joint venture company is based in Gurgaon, India. The company was founded in 2009. Raman Rao has been the CEO of the Indian company since 2020. | Biotechnology | Chairman | |
Chiron Behring & Co.
Chiron Behring & Co. Medical DistributorsDistribution Services Part of Novartis AG, Chiron Behring & Co. is a German company that supplies and develops new vaccine products for adults and children. The company is based in Marburg, Germany. Chiron Behring was acquired by Chiron Corp. from Hoechst AG on April 01, 1998 for $111.90 million. | Medical Distributors | Chief Executive Officer | |
EUROPEAN MEDICAL SOLUTIONS | Biotechnology | Chairman | |
University of Regensburg | College/University | Doctorate Degree |
Statistics
International
Germany | 15 |
Switzerland | 11 |
United States | 10 |
Austria | 5 |
United Kingdom | 5 |
Sectoral
Health Technology | 20 |
Finance | 14 |
Consumer Services | 8 |
Commercial Services | 4 |
Process Industries | 2 |
Operational
Director/Board Member | 40 |
Corporate Officer/Principal | 28 |
Chief Executive Officer | 24 |
Analyst-Equity | 20 |
Director of Finance/CFO | 20 |
Most connected contacts
- Stock Market
- Insiders
- Olav Zilian
- Company connections